Aktiesnakken — April 2011
-
hej actdk. din fornyelse er gået igennem nu, og du skulle have fået plus igen
-
Bavarian Nordics kontrakt om udvikling af frysetørret IMVAMUNE
koppevaccine udvides op til knap DKK 500 mio -
(fra 210 mio kr... ca. 40 mio usd)
-
1000 aktier i parken mere hver til KPS og Skjærbæk. Hvornår lukker deres vindue? så kursen kan falde lidt og vi kan få shoppet?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
Og velkommen i øvrigt..